SOPHiA GENETICS SA: Schindel Yair Chaim amends Schedule 13D stake filing
Not investment advice. Muhabbit scores how much a story may matter, not which way to trade.
Yair Chaim Schindel amended his Schedule 13D filing on SOPHiA GENETICS SA, updating his disclosed stake in the Swiss genomics company. The filing, submitted under SEC accession number 0001178913-26-005168, signals a change in the holdings of a major shareholder. Schedule 13D amendments are typically watched for shifts in activist or large-investor positions. The filing did not disclose the size or direction of the change in the headline. Investors will watch for further detail on Schindel's position and any implications for the company's governance.
Muhabbit's AI wrote this summary in its own words from SEC EDGAR SCHEDULE 13D's report. It can get details wrong, so check the source.
Named in this story
Schindel Yair Chaim, SOPHiA GENETICS SA